ARTICLE | Company News
BresaGen, Opsona deal
August 8, 2005 7:00 AM UTC
BGN will use its protEcol Services technology to conduct feasibility studies and process development for the planned large-scale cGMP manufacture of Opsona's recombinant OPN-201 in E. coli. The im-mun...